LAKE
FOREST, Calif., July 28,
2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:
BIOL), the global leader in dental lasers, today announced that it
will release second quarter 2022 financial and operating results on
Thursday, August 11, 2022 after the
close of the U.S. financial markets and will host a conference call
and webcast that day at 4:30 p.m. ET
/ 1:30 p.m. PT to discuss the results
and corporate developments.
To access the live call, dial 877-545-0320 (U.S.) or +1
973-528-0002 (International) and provide the following earnings
code: 838343.
A live and archived webcast of the conference call will be
accessible on the BIOLASE Investor Relations Page. In addition, a
phone replay will be available approximately two hours following
the end of the call, and it will remain available for one week. To
access the call replay dial 877-481-4010 or +1 919-882-2331
(International) and enter replay passcode: 46222.
About BIOLASE
BIOLASE is a medical device company that develops,
manufactures, markets, and sells laser systems in dentistry and
medicine. BIOLASE's products advance the practice of dentistry and
medicine for patients and healthcare professionals. BIOLASE's
proprietary laser products incorporate approximately 302 patented
and 31 patent-pending technologies designed to provide biologically
and clinically superior performance with less pain and faster
recovery times. BIOLASE's innovative products provide cutting-edge
technology at competitive prices to deliver superior results for
dentists and patients. BIOLASE's principal products are
revolutionary dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical
applications. BIOLASE has sold over 43,300 laser systems
to date in over 80 countries around the world. Laser products under
development address BIOLASE's core dental market and other adjacent
medical and consumer applications.
For updates and information on Waterlase iPlus®,
Waterlase Express™, and laser dentistry,
find BIOLASE online
at www.biolase.com, Facebook at www.facebook.com/biolase,
Twitter at www.twitter.com/biolaseinc, Instagram
at www.instagram.com/waterlase_laserdentistry, and LinkedIn
at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase
iPlus® are registered trademarks of BIOLASE,
Inc.
Contacts:
EVC Group, Inc.
Michael Polyviou/Todd Kehrli
(732) 232-6914
mpolyviou@evcgroup.com; tkehrli@evcgroup.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolase-inc-to-report-second-quarter-2022-results-on-august-11-2022-301594613.html
SOURCE BIOLASE, Inc.